v3.26.1
Condensed Statement of Cash Flows - USD ($)
 3 Months Ended 4 Months Ended 6 Months Ended 12 Months Ended
Feb. 25, 2026
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities:              
Net loss $ (33,697) $ 54,050 $ (11,199)        
Adjustments to reconcile net loss to net cash used in operating activities:              
Interest earned on marketable securities held in Trust Account   (238,468) (238,468)        
General and administrative expenses paid through issuance of Class B ordinary shares to Sponsor 25,000            
Changes in operating liabilities:              
Prepaid expenses     (235,857)        
Accounts payable and accrued expenses     55,587        
Accrued expenses 8,697            
Net cash used in operating activities 0   (429,937)        
Cash Flows from Investing Activities              
Cash deposited in Trust Account     (75,000,000)        
Net cash used in investing activities     (75,000,000)        
Cash Flows from Financing Activities:              
Proceeds from issuance of Class B ordinary shares to Sponsor     25,000        
Proceeds from Promissory Note - Sponsor     300,000        
Repayment of Promissory Note - Sponsor     (300,000)        
Proceeds received from Initial Public Offering of Public Shares, net of underwriting commissions     75,000,000        
Proceeds from the sale of Private Placement Shares   2,750,000 2,750,000        
Payment of offering costs     (1,512,251)        
Net cash provided by financing activities     76,262,749        
Net Change in Cash 0   832,812        
Cash – beginning of the period 0   0        
Cash – end of the period 0 832,812 832,812   $ 832,812    
Supplemental disclosure of non-cash investing and financing activities:              
Deferred underwriting fee payable     2,250,000        
Remeasurement of Class A ordinary shares subject to possible redemption to redemption value   (4,000,719) 4,000,719        
Deferred offering costs included in accrued offering costs 128,033            
General and administrative costs paid by Sponsor in exchange for issuance of Class B ordinary shares $ 25,000            
OHB Pediatrics Ltd [Member]              
Cash Flows from Operating Activities:              
Net loss       $ (357,000) (13,507,000) $ (2,958,000) $ (15,650,000)
Changes in operating liabilities:              
Prepaid expenses       (14,000) (364,000) (218,000) (1,214,000)
Accounts payable and accrued expenses       230,000 5,253,000 163,000 1,298,000
Prepaid taxes       0 (187,000) (204,000) (226,000)
Deposits       0 (2,963,000) (43,000) (43,000)
Net cash used in operating activities       (141,000) (11,768,000) (3,260,000) (15,835,000)
Cash Flows from Financing Activities:              
Payments by Parent Co. on behalf of OHB Pediatrics, Ltd.       141,000 7,301,000 3,260,000 15,835,000
Payments of deferred offering costs         (441,000) 0  
Net cash provided by financing activities       141,000 38,750,000 3,260,000 15,835,000
Net Change in Cash       0 26,982,000 0 0
Cash – beginning of the period       0 0 0 0
Cash – end of the period   $ 26,982,000 $ 26,982,000 0 26,982,000 0 0
Supplemental disclosure of non-cash investing and financing activities:              
Issuance of shares       $ 0     $ 15,976,000
Non-cash recognition of deferred offering costs         251,000 0  
OHB Pediatrics Ltd [Member] | Series A Redeemable Preferred Stock [Member]              
Cash Flows from Financing Activities:              
Proceeds received from issuance of Series A redeemable convertible preferred stock, net         $ 31,890,000 $ 0